VYNE Therapeutics Inc. (VYNE) NASDAQ
$2.65 0.33 (14.22%)
Market Cap: $32.71M
As of 04/24/24 03:14 PM EDT. Market closed.
VYNE Therapeutics Inc. (VYNE)
NASDAQ
$2.65
0.33 (14.22%)
Market Cap: $32.71M
As of 04/24/24 03:14 PM EDT. Market closed.
Add to Portfolio
vyne therapeutics inc., a pharmaceutical company, focuses on developing and commercializing various therapeutics for dermatology. it offers amzeeq, a topical minocycline used for the treatment of inflammatory lesions of non-nodular moderate-to-severe acne vulgaris in patients 9 years of age and older. the company is also developing fmx103, which is in phase iii clinical trials for the treatment ... read more
COMPANY PROFILE
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
URL
Address
.
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Full Time Employees
29
URL
Address
.
PRICE CHART FOR VYNE THERAPEUTICS INC
From:
To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$2.39
Previous Close
$2.32
Days Range
$2.27 - $2.35
52 week range
$1.67 - $8.73
Volume
384,753
Avg. Volume (30 days)
105,723
Market Cap
$32.71M
Dividend Yield
-
P/E
(1.15)
Shares Outstanding
14,098,888
Open
$2.39
Previous Close
$2.32
Days Range
$2.27 - $2.35
52 week range
$1.67 - $8.73
Volume
384,753
Avg. Volume (30 days)
105,723
Market Cap
$32.71M
Dividend Yield
-
P/E
(1.15)
Shares Outstanding
14,098,888
FINANCIAL STATEMENTS FOR VYNE THERAPEUTICS INC
LOADING...
Open in: 
Open in:
INSIDER TRANSACTIONS FOR VYNE THERAPEUTICS INC
| Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
| Zeronda Tyler | CHIEF FINANCIAL OFFICER | Apr 01, 2024 | Option Exercise | $3.08 | 94 | 290 | 131,743 | Apr 03, 2024, 05:08 PM |
| Stuart Iain | CHIEF SCIENTIFIC OFFICER | Apr 01, 2024 | Option Exercise | $3.08 | 157 | 484 | 133,741 | Apr 03, 2024, 05:06 PM |
| Harsch Mutya | CHIEF LEGAL OFFICER AND GC | Apr 01, 2024 | Option Exercise | $3.08 | 161 | 496 | 149,274 | Apr 03, 2024, 05:04 PM |
| Domzalski David | PRESIDENT AND CEO | Apr 01, 2024 | Option Exercise | $3.08 | 1,004 | 3,092 | 494,160 | Apr 03, 2024, 05:02 PM |
| Zeronda Tyler | Chief Financial Officer | Jan 02, 2024 | Option Exercise | $2.28 | 93 | 212 | 131,837 | Jan 03, 2024, 05:22 PM |
| Stuart Iain | Chief Scientific Officer | Jan 02, 2024 | Option Exercise | $2.28 | 157 | 358 | 133,898 | Jan 03, 2024, 05:21 PM |
| Harsch Mutya | Chief Legal Officer and GC | Jan 02, 2024 | Option Exercise | $2.28 | 161 | 367 | 149,435 | Jan 03, 2024, 05:20 PM |
| Domzalski David | President and CEO | Nov 30, 2023 | Option Exercise | $2.81 | 2,284 | 6,426 | 46,168 | Dec 04, 2023, 04:30 PM |
| LEPORE PATRICK G | Director | Nov 15, 2023 | Buy | $3.91 | 13,000 | 50,778 | 36,472 | Nov 17, 2023, 05:03 PM |
| Zeronda Tyler | Chief Financial Officer | Oct 02, 2023 | Option Exercise | $3.83 | 1,087 | 4,163 | 6,930 | Oct 04, 2023, 04:26 PM |
| Stuart Iain | Chief Scientific Officer | Oct 02, 2023 | Option Exercise | $3.83 | 1,184 | 4,535 | 9,055 | Oct 04, 2023, 04:23 PM |
| Harsch Mutya | Chief Legal Officer and GC | Oct 02, 2023 | Option Exercise | $3.83 | 1,154 | 4,420 | 24,596 | Oct 04, 2023, 04:21 PM |
| Domzalski David | President and CEO | Oct 02, 2023 | Option Exercise | $3.83 | 8,549 | 32,743 | 43,884 | Oct 04, 2023, 04:19 PM |
| Zeronda Tyler | Chief Financial Officer | Jun 30, 2023 | Option Exercise | $4.10 | 91 | 373 | 8,017 | Jul 05, 2023, 04:37 PM |
| Harsch Mutya | Chief Legal Officer and GC | May 31, 2023 | Option Exercise | $3.46 | 3,664 | 12,664 | 25,907 | Jun 02, 2023, 04:34 PM |
| Domzalski David | President and CEO | May 31, 2023 | Option Exercise | $3.46 | 2,766 | 9,560 | 53,414 | Jun 02, 2023, 04:31 PM |
| Zeronda Tyler | Chief Financial Officer | Mar 31, 2023 | Option Exercise | $3.08 | 384 | 1,183 | 8,108 | Apr 04, 2023, 05:07 PM |
| Stuart Iain | Chief Scientific Officer | Mar 31, 2023 | Option Exercise | $3.08 | 480 | 1,478 | 10,390 | Apr 04, 2023, 05:05 PM |
| LEPORE PATRICK G | Director | Mar 20, 2023 | Buy | $2.48 | 20,000 | 49,680 | 23,472 | Mar 22, 2023, 04:03 PM |
| Harsch Mutya | Chief Legal Officer and GC | Mar 20, 2023 | Buy | $2.50 | 10,000 | 25,000 | 22,721 | Mar 22, 2023, 04:01 PM |
| Harsch Mutya | Chief Legal Officer and GC | Dec 31, 2022 | Option Exercise | $0.15 | 1,813 | 272 | 229,144 | Jan 04, 2023, 05:12 PM |
| Stuart Iain | Chief Scientific Officer | Dec 31, 2022 | Option Exercise | $0.15 | 1,720 | 258 | 220,252 | Jan 04, 2023, 05:09 PM |
| Zeronda Tyler | Chief Financial Officer | Dec 31, 2022 | Option Exercise | $0.15 | 354 | 53 | 173,005 | Jan 04, 2023, 05:05 PM |
| Domzalski David | President and CEO | Dec 31, 2022 | Option Exercise | $0.15 | 10,685 | 1,603 | 1,064,290 | Jan 04, 2023, 05:03 PM |
| Domzalski David | President and CEO | Nov 30, 2022 | Option Exercise | $0.20 | 34,705 | 6,861 | 1,074,975 | Dec 02, 2022, 04:30 PM |
| Zeronda Tyler | CFO | Sep 30, 2022 | Option Exercise | $0.22 | 353 | 79 | 173,359 | Oct 04, 2022, 05:05 PM |
| Stuart Iain | Chief Scientific Officer | Sep 30, 2022 | Option Exercise | $0.22 | 1,719 | 383 | 221,972 | Oct 04, 2022, 05:05 PM |
| Harsch Mutya | Chief Legal Officer and GC | Sep 30, 2022 | Option Exercise | $0.22 | 1,813 | 404 | 230,957 | Oct 04, 2022, 05:04 PM |
| Domzalski David | President and CEO | Sep 30, 2022 | Option Exercise | $0.22 | 10,683 | 2,382 | 1,040,270 | Oct 04, 2022, 05:00 PM |
| Zeronda Tyler | CFO | Jun 30, 2022 | Option Exercise | $0.39 | 354 | 138 | 173,712 | Jul 05, 2022, 05:01 PM |
| Stuart Iain | Chief Scientific Officer | Jun 30, 2022 | Option Exercise | $0.39 | 1,719 | 669 | 223,691 | Jul 05, 2022, 05:01 PM |
| Harsch Mutya | Chief Legal Officer and GC | Jun 30, 2022 | Option Exercise | $0.39 | 1,813 | 705 | 232,770 | Jul 05, 2022, 05:00 PM |
| Domzalski David | President and CEO | Jun 30, 2022 | Option Exercise | $0.39 | 10,683 | 4,156 | 1,050,953 | Jul 05, 2022, 05:00 PM |
| Zeronda Tyler | CFO | May 31, 2022 | Option Exercise | $0.35 | 12,510 | 4,332 | 174,066 | Jun 02, 2022, 04:36 PM |
| Domzalski David | President and CEO | May 31, 2022 | Option Exercise | $0.35 | 11,887 | 4,116 | 1,061,636 | Jun 02, 2022, 04:35 PM |
| Zeronda Tyler | CFO | Mar 31, 2022 | Option Exercise | $0.65 | 773 | 502 | 161,556 | Apr 04, 2022, 05:10 PM |
| Stuart Iain | Chief Scientific Officer | Mar 31, 2022 | Option Exercise | $0.65 | 3,469 | 2,255 | 225,410 | Apr 04, 2022, 05:09 PM |
| Harsch Mutya | Chief Legal Officer and GC | Mar 31, 2022 | Option Exercise | $0.65 | 3,630 | 2,359 | 234,583 | Apr 04, 2022, 05:09 PM |
| Domzalski David | President and CEO | Mar 31, 2022 | Option Exercise | $0.65 | 23,186 | 15,071 | 1,049,749 | Apr 04, 2022, 05:08 PM |
| Stuart Iain | Chief Scientific Officer | Dec 31, 2021 | Option Exercise | $1.02 | 1,250 | 1,275 | 153,879 | Jan 04, 2022, 04:40 PM |
| Harsch Mutya | Chief Legal Officer and GC | Dec 31, 2021 | Option Exercise | $1.02 | 1,484 | 1,514 | 163,213 | Jan 04, 2022, 04:40 PM |
| Zeronda Tyler | Interim CFO | Nov 30, 2021 | Option Exercise | $0.88 | 4,187 | 3,666 | 87,535 | Dec 02, 2021, 05:08 PM |
| LEPORE PATRICK G | Director | Nov 30, 2021 | Buy | $1.02 | 12,500 | 12,699 | 62,500 | Dec 02, 2021, 05:08 PM |
| Domzalski David | President and CEO | Nov 30, 2021 | Option Exercise | $0.88 | 4,705 | 4,119 | 767,520 | Dec 02, 2021, 05:07 PM |
| Zeronda Tyler | Interim CFO | Sep 30, 2021 | Option Exercise | $1.39 | 206 | 286 | 83,348 | Oct 01, 2021, 05:12 PM |
| Stuart Iain | Chief Scientific Officer | Sep 30, 2021 | Option Exercise | $1.39 | 1,480 | 2,057 | 155,129 | Oct 01, 2021, 05:12 PM |
| Harsch Mutya | Chief Legal Officer and GC | Sep 30, 2021 | Option Exercise | $1.39 | 1,484 | 2,063 | 164,697 | Oct 01, 2021, 05:11 PM |
| Domzalski David | President and CEO | Sep 30, 2021 | Option Exercise | $1.39 | 13,096 | 18,203 | 762,815 | Oct 01, 2021, 05:10 PM |
| LEPORE PATRICK G | Director | Aug 25, 2021 | Buy | $1.60 | 12,500 | 20,000 | 50,000 | Aug 26, 2021, 05:04 PM |
| PERCEPTIVE ADVISORS LLC | 10% Owner | Aug 16, 2021 | Sale | $1.74 | 250,000 | 435,000 | 4,935,057 | Aug 18, 2021, 07:19 PM |
| PERCEPTIVE ADVISORS LLC | 10% Owner | Aug 13, 2021 | Sale | $1.84 | 250,000 | 460,000 | 5,185,057 | Aug 17, 2021, 04:46 PM |
| PERCEPTIVE ADVISORS LLC | 10% Owner | Aug 12, 2021 | Sale | $2.23 | 338,897 | 755,740 | 5,435,057 | Aug 16, 2021, 06:24 PM |
| Zeronda Tyler | Interim CFO | Jun 30, 2021 | Option Exercise | $3.51 | 700 | 2,457 | 22,695 | Jul 02, 2021, 04:37 PM |
| Wiley Matthew T. | Chief Commercial Officer | Jun 30, 2021 | Option Exercise | $3.51 | 5,151 | 18,080 | 109,246 | Jul 02, 2021, 04:36 PM |
| Stuart Iain | Chief Scientific Officer | Jun 30, 2021 | Option Exercise | $3.51 | 3,083 | 10,821 | 95,750 | Jul 02, 2021, 04:36 PM |
| Harsch Mutya | Chief Legal Officer and GC | Jun 30, 2021 | Option Exercise | $3.51 | 3,551 | 12,464 | 105,322 | Jul 02, 2021, 04:36 PM |
| Domzalski David | President and CEO | Jun 30, 2021 | Option Exercise | $3.51 | 18,859 | 66,195 | 455,599 | Jul 02, 2021, 04:35 PM |
| LEPORE PATRICK G | Director | May 26, 2021 | Buy | $3.60 | 12,500 | 44,958 | 37,500 | May 27, 2021, 05:18 PM |
| PERCEPTIVE ADVISORS LLC | 10% Owner | May 06, 2021 | Sale | $3.67 | 1,000,000 | 3,670,000 | 5,773,954 | May 07, 2021, 05:31 PM |
| Wiley Matthew T. | Chief Commercial Officer | Mar 31, 2021 | Option Exercise | $6.84 | 2,573 | 17,599 | 114,397 | Apr 02, 2021, 12:15 PM |
| Stuart Iain | Chief Scientific Officer | Mar 31, 2021 | Option Exercise | $6.84 | 1,945 | 13,304 | 98,833 | Apr 02, 2021, 12:14 PM |
| Saik Andrew | Chief Financial Officer | Mar 31, 2021 | Option Exercise | $6.84 | 762 | 5,212 | 113,451 | Apr 02, 2021, 12:14 PM |
| Harsch Mutya | Chief Legal Officer and GC | Mar 31, 2021 | Option Exercise | $6.84 | 1,765 | 12,073 | 108,873 | Apr 02, 2021, 12:14 PM |
| Domzalski David | President and CEO | Mar 31, 2021 | Option Exercise | $6.84 | 6,316 | 43,201 | 473,517 | Apr 02, 2021, 12:13 PM |
| LEPORE PATRICK G | Director | Mar 15, 2021 | Buy | $7.41 | 12,500 | 92,563 | 25,000 | Mar 16, 2021, 04:38 PM |
| PERCEPTIVE ADVISORS LLC | 10% Owner | Jan 28, 2021 | Buy | $2.37 | 4,219,409 | 9,999,999 | 27,095,819 | Feb 01, 2021, 05:31 PM |
| Wiley Matthew T. | Chief Commercial Officer | Dec 31, 2020 | Option Exercise | $1.58 | 1,541 | 2,435 | 357,181 | Jan 05, 2021, 04:32 PM |
| Domzalski David | President and CEO | Dec 31, 2020 | Option Exercise | $1.58 | 9,656 | 15,256 | 1,304,334 | Jan 05, 2021, 04:32 PM |
| Harsch Mutya | Chief Legal Officer and GC | Dec 31, 2020 | Option Exercise | $1.58 | 1,822 | 2,879 | 325,703 | Jan 05, 2021, 12:00 AM |
| Stuart Iain | Chief Scientific Officer | Dec 31, 2020 | Option Exercise | $1.58 | 2,378 | 3,757 | 286,262 | Jan 05, 2021, 12:00 AM |
| LEPORE PATRICK G | Director | Dec 03, 2020 | Buy | $1.71 | 50,000 | 85,425 | 50,000 | Dec 07, 2020, 04:31 PM |
| Wiley Matthew T. | Chief Commercial Officer | Nov 30, 2020 | Option Exercise | $1.45 | 7,838 | 11,326 | 358,722 | Dec 02, 2020, 04:31 PM |
| Harsch Mutya | Chief Legal Officer and GC | Nov 30, 2020 | Option Exercise | $1.45 | 10,460 | 15,115 | 327,525 | Dec 02, 2020, 04:31 PM |
| Domzalski David | President and CEO | Nov 30, 2020 | Option Exercise | $1.45 | 4,263 | 6,160 | 1,313,990 | Dec 02, 2020, 04:30 PM |
| Wiley Matthew T. | Chief Commercial Officer | Sep 30, 2020 | Option Exercise | $1.66 | 1,541 | 2,558 | 350,884 | Oct 02, 2020, 04:32 PM |
| Stuart Iain | Chief Scientific Officer | Sep 30, 2020 | Option Exercise | $1.66 | 2,378 | 3,947 | 288,640 | Oct 02, 2020, 04:32 PM |
| Harsch Mutya | Chief Legal Officer and GC | Sep 30, 2020 | Option Exercise | $1.66 | 1,822 | 3,025 | 317,065 | Oct 02, 2020, 04:31 PM |
| Domzalski David | President and CEO | Sep 30, 2020 | Option Exercise | $1.66 | 6,239 | 10,357 | 1,309,727 | Oct 02, 2020, 04:31 PM |
| Saik Andrew | Chief Financial Officer | Sep 08, 2020 | Buy | $1.46 | 40,000 | 58,480 | 340,000 | Sep 08, 2020, 08:01 PM |
| Domzalski David | President and CEO | Sep 08, 2020 | Buy | $1.38 | 75,000 | 103,568 | 1,315,966 | Sep 08, 2020, 08:00 PM |
| BARBARI SHARON | Director | Aug 20, 2020 | Option Exercise | $1.48 | 75,000 | 111,000 | 75,000 | Aug 21, 2020, 05:00 PM |
| Wiley Matthew T. | Chief Commercial Officer | Jun 30, 2020 | Option Exercise | $1.73 | 1,541 | 2,666 | 352,425 | Jul 02, 2020, 04:25 PM |
| Stuart Iain | Chief Scientific Officer | Jun 30, 2020 | Option Exercise | $1.73 | 2,378 | 4,114 | 291,018 | Jul 02, 2020, 04:25 PM |
| Harsch Mutya | Chief Legal Officer and GC | Jun 30, 2020 | Option Exercise | $1.73 | 1,822 | 3,152 | 318,887 | Jul 02, 2020, 04:24 PM |
| Domzalski David | President and CEO | Jun 30, 2020 | Option Exercise | $1.73 | 6,239 | 10,793 | 1,240,966 | Jul 02, 2020, 04:22 PM |
| PERCEPTIVE ADVISORS LLC | 10% Owner | Jun 09, 2020 | Buy | $1.85 | 2,702,702 | 4,999,999 | 22,876,410 | Jun 11, 2020, 07:33 PM |
| Wiley Matthew T. | Chief Commercial Officer | Apr 06, 2020 | Option Exercise | $1.40 | 908 | 1,271 | 203,967 | Apr 07, 2020, 05:23 PM |
| Stuart Iain | Chief Scientific Officer | Apr 06, 2020 | Option Exercise | $1.40 | 3,763 | 5,268 | 180,901 | Apr 07, 2020, 05:22 PM |
| Harsch Mutya | Chief Legal Officer and GC | Apr 06, 2020 | Option Exercise | $1.40 | 4,474 | 6,264 | 170,712 | Apr 07, 2020, 05:22 PM |
| Domzalski David | President and CEO | Apr 06, 2020 | Option Exercise | $1.40 | 11,772 | 16,481 | 567,213 | Apr 07, 2020, 05:21 PM |
| Harsch Mutya | Chief Legal Officer and GC | Mar 31, 2020 | Option Exercise | $2.68 | 1,688 | 4,524 | 56,503 | Apr 02, 2020, 04:47 PM |
| Wiley Matthew T. | Chief Commercial Officer | Mar 31, 2020 | Option Exercise | $2.68 | 525 | 1,407 | 67,051 | Apr 02, 2020, 04:41 PM |
| Stuart Iain | Chief Scientific Officer | Mar 31, 2020 | Option Exercise | $2.68 | 1,940 | 5,199 | 59,452 | Apr 02, 2020, 04:41 PM |
| Domzalski David | President and CEO | Mar 31, 2020 | Option Exercise | $2.68 | 4,456 | 11,942 | 187,496 | Apr 02, 2020, 04:32 PM |
| BALL KRISTINE M | See Remarks | Dec 11, 2019 | Option Exercise | $4.52 | 27,766 | 125,502 | 52,534 | Dec 16, 2019, 05:14 PM |
| Kwon Paul | Chief Scientific Officer | Dec 11, 2019 | Option Exercise | $4.52 | 27,766 | 125,502 | 52,534 | Dec 16, 2019, 05:13 PM |
| Basta Steven L | Chief Executive Officer | Dec 11, 2019 | Option Exercise | $4.52 | 85,210 | 385,149 | 495,764 | Dec 16, 2019, 05:11 PM |
| Basta Steven L | Chief Executive Officer | Dec 11, 2019 | Option Exercise | $1.83 | 14,000 | 25,620 | 509,764 | Dec 16, 2019, 05:11 PM |
| Kwon Paul | Chief Scientific Officer | Dec 11, 2019 | Option Exercise | $4.52 | 27,766 | 125,502 | 52,534 | Dec 13, 2019, 09:59 PM |
| Krasnow Ronald A. | See Remarks | Dec 11, 2019 | Option Exercise | $4.52 | 8,271 | 37,385 | 15,819 | Dec 13, 2019, 09:58 PM |
| BALL KRISTINE M | See Remarks | Dec 11, 2019 | Option Exercise | $4.52 | 27,766 | 125,502 | 52,534 | Dec 13, 2019, 09:56 PM |
| Basta Steven L | Chief Executive Officer | Dec 11, 2019 | Option Exercise | $4.52 | 85,210 | 385,149 | 495,764 | Dec 13, 2019, 09:54 PM |
| Basta Steven L | Chief Executive Officer | Dec 11, 2019 | Option Exercise | $1.83 | 14,000 | 25,620 | 509,764 | Dec 13, 2019, 09:54 PM |
| Presidio Partners 2007 GP, L.P. | Former 10% Owner | Jul 24, 2018 | Sale | $7.65 | 12,500 | 95,625 | 48,910 | Jul 26, 2018, 07:11 PM |
| Presidio Partners 2007 GP, L.P. | Former 10% Owner | Jul 24, 2018 | Sale | $7.65 | 487,500 | 3,729,375 | 1,907,568 | Jul 26, 2018, 07:11 PM |
| venBio Global Strategic Fund II L.P. | 10% Owner | Jan 25, 2018 | Buy | $17.00 | 265,000 | 4,505,000 | 265,000 | Jan 29, 2018, 04:22 PM |
| Remeditex Ventures LLC | 10% Owner | Jan 25, 2018 | Buy | $17.00 | 100,000 | 1,700,000 | 1,582,854 | Jan 29, 2018, 04:19 PM |
| Vivo Capital VIII, LLC | 10% Owner | Jan 25, 2018 | Buy | $17.00 | 35,686 | 606,662 | 35,686 | Jan 29, 2018, 04:17 PM |
| Vivo Capital VIII, LLC | 10% Owner | Jan 25, 2018 | Buy | $17.00 | 258,432 | 4,393,344 | 258,432 | Jan 29, 2018, 04:17 PM |
| Cha Albert | Director | Jan 25, 2018 | Buy | $17.00 | 35,686 | 606,662 | 35,686 | Jan 29, 2018, 04:14 PM |
| Cha Albert | Director | Jan 25, 2018 | Buy | $17.00 | 258,432 | 4,393,344 | 258,432 | Jan 29, 2018, 04:14 PM |
Load More Insider Transactions
Buy
Sale
Option Exercise
| Owner | Relationship | Date | Value($) |
| Zeronda Tyler | CHIEF FINANCIAL OFFICER | 04/01/2024 | 290 |
| Stuart Iain | CHIEF SCIENTIFIC OFFICER | 04/01/2024 | 484 |
| Harsch Mutya | CHIEF LEGAL OFFICER AND GC | 04/01/2024 | 496 |
| Domzalski David | PRESIDENT AND CEO | 04/01/2024 | 3,092 |
| Zeronda Tyler | Chief Financial Officer | 01/02/2024 | 212 |
| Stuart Iain | Chief Scientific Officer | 01/02/2024 | 358 |
| Harsch Mutya | Chief Legal Officer and GC | 01/02/2024 | 367 |
| Domzalski David | President and CEO | 11/30/2023 | 6,426 |
| LEPORE PATRICK G | Director | 11/15/2023 | 50,778 |
| Zeronda Tyler | Chief Financial Officer | 10/02/2023 | 4,163 |
| Stuart Iain | Chief Scientific Officer | 10/02/2023 | 4,535 |
| Harsch Mutya | Chief Legal Officer and GC | 10/02/2023 | 4,420 |
| Domzalski David | President and CEO | 10/02/2023 | 32,743 |
| Zeronda Tyler | Chief Financial Officer | 06/30/2023 | 373 |
| Harsch Mutya | Chief Legal Officer and GC | 05/31/2023 | 12,664 |
| Domzalski David | President and CEO | 05/31/2023 | 9,560 |
| Zeronda Tyler | Chief Financial Officer | 03/31/2023 | 1,183 |
| Stuart Iain | Chief Scientific Officer | 03/31/2023 | 1,478 |
| LEPORE PATRICK G | Director | 03/20/2023 | 49,680 |
| Harsch Mutya | Chief Legal Officer and GC | 03/20/2023 | 25,000 |
| Harsch Mutya | Chief Legal Officer and GC | 12/31/2022 | 272 |
| Stuart Iain | Chief Scientific Officer | 12/31/2022 | 258 |
| Zeronda Tyler | Chief Financial Officer | 12/31/2022 | 53 |
| Domzalski David | President and CEO | 12/31/2022 | 1,603 |
| Domzalski David | President and CEO | 11/30/2022 | 6,861 |
| Zeronda Tyler | CFO | 09/30/2022 | 79 |
| Stuart Iain | Chief Scientific Officer | 09/30/2022 | 383 |
| Harsch Mutya | Chief Legal Officer and GC | 09/30/2022 | 404 |
| Domzalski David | President and CEO | 09/30/2022 | 2,382 |
| Zeronda Tyler | CFO | 06/30/2022 | 138 |
| Stuart Iain | Chief Scientific Officer | 06/30/2022 | 669 |
| Harsch Mutya | Chief Legal Officer and GC | 06/30/2022 | 705 |
| Domzalski David | President and CEO | 06/30/2022 | 4,156 |
| Zeronda Tyler | CFO | 05/31/2022 | 4,332 |
| Domzalski David | President and CEO | 05/31/2022 | 4,116 |
| Zeronda Tyler | CFO | 03/31/2022 | 502 |
| Stuart Iain | Chief Scientific Officer | 03/31/2022 | 2,255 |
| Harsch Mutya | Chief Legal Officer and GC | 03/31/2022 | 2,359 |
| Domzalski David | President and CEO | 03/31/2022 | 15,071 |
| Stuart Iain | Chief Scientific Officer | 12/31/2021 | 1,275 |
| Harsch Mutya | Chief Legal Officer and GC | 12/31/2021 | 1,514 |
| Zeronda Tyler | Interim CFO | 11/30/2021 | 3,666 |
| LEPORE PATRICK G | Director | 11/30/2021 | 12,699 |
| Domzalski David | President and CEO | 11/30/2021 | 4,119 |
| Zeronda Tyler | Interim CFO | 09/30/2021 | 286 |
| Stuart Iain | Chief Scientific Officer | 09/30/2021 | 2,057 |
| Harsch Mutya | Chief Legal Officer and GC | 09/30/2021 | 2,063 |
| Domzalski David | President and CEO | 09/30/2021 | 18,203 |
| LEPORE PATRICK G | Director | 08/25/2021 | 20,000 |
| PERCEPTIVE ADVISORS LLC | 10% Owner | 08/16/2021 | 435,000 |
| PERCEPTIVE ADVISORS LLC | 10% Owner | 08/13/2021 | 460,000 |
| PERCEPTIVE ADVISORS LLC | 10% Owner | 08/12/2021 | 755,740 |
| Zeronda Tyler | Interim CFO | 06/30/2021 | 2,457 |
| Wiley Matthew T. | Chief Commercial Officer | 06/30/2021 | 18,080 |
| Stuart Iain | Chief Scientific Officer | 06/30/2021 | 10,821 |
| Harsch Mutya | Chief Legal Officer and GC | 06/30/2021 | 12,464 |
| Domzalski David | President and CEO | 06/30/2021 | 66,195 |
| LEPORE PATRICK G | Director | 05/26/2021 | 44,958 |
| PERCEPTIVE ADVISORS LLC | 10% Owner | 05/06/2021 | 3,670,000 |
| Wiley Matthew T. | Chief Commercial Officer | 03/31/2021 | 17,599 |
| Stuart Iain | Chief Scientific Officer | 03/31/2021 | 13,304 |
| Saik Andrew | Chief Financial Officer | 03/31/2021 | 5,212 |
| Harsch Mutya | Chief Legal Officer and GC | 03/31/2021 | 12,073 |
| Domzalski David | President and CEO | 03/31/2021 | 43,201 |
| LEPORE PATRICK G | Director | 03/15/2021 | 92,563 |
| PERCEPTIVE ADVISORS LLC | 10% Owner | 01/28/2021 | 9,999,999 |
| Wiley Matthew T. | Chief Commercial Officer | 12/31/2020 | 2,435 |
| Domzalski David | President and CEO | 12/31/2020 | 15,256 |
| Harsch Mutya | Chief Legal Officer and GC | 12/31/2020 | 2,879 |
| Stuart Iain | Chief Scientific Officer | 12/31/2020 | 3,757 |
| LEPORE PATRICK G | Director | 12/03/2020 | 85,425 |
| Wiley Matthew T. | Chief Commercial Officer | 11/30/2020 | 11,326 |
| Harsch Mutya | Chief Legal Officer and GC | 11/30/2020 | 15,115 |
| Domzalski David | President and CEO | 11/30/2020 | 6,160 |
| Wiley Matthew T. | Chief Commercial Officer | 09/30/2020 | 2,558 |
| Stuart Iain | Chief Scientific Officer | 09/30/2020 | 3,947 |
| Harsch Mutya | Chief Legal Officer and GC | 09/30/2020 | 3,025 |
| Domzalski David | President and CEO | 09/30/2020 | 10,357 |
| Saik Andrew | Chief Financial Officer | 09/08/2020 | 58,480 |
| Domzalski David | President and CEO | 09/08/2020 | 103,568 |
| BARBARI SHARON | Director | 08/20/2020 | 111,000 |
| Wiley Matthew T. | Chief Commercial Officer | 06/30/2020 | 2,666 |
| Stuart Iain | Chief Scientific Officer | 06/30/2020 | 4,114 |
| Harsch Mutya | Chief Legal Officer and GC | 06/30/2020 | 3,152 |
| Domzalski David | President and CEO | 06/30/2020 | 10,793 |
| PERCEPTIVE ADVISORS LLC | 10% Owner | 06/09/2020 | 4,999,999 |
| Wiley Matthew T. | Chief Commercial Officer | 04/06/2020 | 1,271 |
| Stuart Iain | Chief Scientific Officer | 04/06/2020 | 5,268 |
| Harsch Mutya | Chief Legal Officer and GC | 04/06/2020 | 6,264 |
| Domzalski David | President and CEO | 04/06/2020 | 16,481 |
| Harsch Mutya | Chief Legal Officer and GC | 03/31/2020 | 4,524 |
| Wiley Matthew T. | Chief Commercial Officer | 03/31/2020 | 1,407 |
| Stuart Iain | Chief Scientific Officer | 03/31/2020 | 5,199 |
| Domzalski David | President and CEO | 03/31/2020 | 11,942 |
| BALL KRISTINE M | See Remarks | 12/11/2019 | 125,502 |
| Kwon Paul | Chief Scientific Officer | 12/11/2019 | 125,502 |
| Basta Steven L | Chief Executive Officer | 12/11/2019 | 385,149 |
| Basta Steven L | Chief Executive Officer | 12/11/2019 | 25,620 |
| Kwon Paul | Chief Scientific Officer | 12/11/2019 | 125,502 |
| Krasnow Ronald A. | See Remarks | 12/11/2019 | 37,385 |
| BALL KRISTINE M | See Remarks | 12/11/2019 | 125,502 |
| Basta Steven L | Chief Executive Officer | 12/11/2019 | 385,149 |
| Basta Steven L | Chief Executive Officer | 12/11/2019 | 25,620 |
| Presidio Partners 2007 GP, L.P. | Former 10% Owner | 07/24/2018 | 95,625 |
| Presidio Partners 2007 GP, L.P. | Former 10% Owner | 07/24/2018 | 3,729,375 |
| venBio Global Strategic Fund II L.P. | 10% Owner | 01/25/2018 | 4,505,000 |
| Remeditex Ventures LLC | 10% Owner | 01/25/2018 | 1,700,000 |
| Vivo Capital VIII, LLC | 10% Owner | 01/25/2018 | 606,662 |
| Vivo Capital VIII, LLC | 10% Owner | 01/25/2018 | 4,393,344 |
| Cha Albert | Director | 01/25/2018 | 606,662 |
| Cha Albert | Director | 01/25/2018 | 4,393,344 |
Load More Insider Transactions
FUNDS WITH A POSITION IN VYNE THERAPEUTICS INC
| Fund | # Shares Owned | % of Portfolio | % Change | Investing Style |
|---|---|---|---|---|
| PALO ALTO INVESTORS LP | 445,434 | 0.09% | New | Other |
| GEODE CAPITAL MANAGEMENT, LLC | 94,343 | 0.00002% | 242.64% | Other |
| BLACKROCK INC. | 47,297 | 0% | 5.25% | Other |
| RENAISSANCE TECHNOLOGIES LLC | 46,376 | 0.00017% | 78.53% | Other |
BUYBACK ANNOUNCEMENT(S) FOR VYNE THERAPEUTICS INC
LOADING...